NCT07160634Phase 3Recruiting

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

Study sponsor: Solid Biosciences Inc. · SLDB

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-01Estimated
Enrollment · participants80Estimated
Source updated2026-11-20Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source